Immunity to asexual blood stage malaria and vaccine approaches (Q34842236)

4 August 2017

1 reference

title

Immunity to asexual blood stage malaria and vaccine approaches (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

4

Michael F Good

1 reference

4 August 2017

1

Jiraprapa Wipasa

1 reference

4 August 2017

Salenna Elliott

2

1 reference

PubMed ID

12225376

4 August 2017

Huji Xu

series ordinal

3

1 reference

4 August 2017

1 October 2002

1 reference

Immunology & Cell Biology

4 August 2017

1 reference

4 August 2017

80

1 reference

4 August 2017

401-414

1 reference

4 August 2017

5

1 reference

Abnormal blood flow and red blood cell deformability in severe malaria

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

21 January 2018

Pathogenesis of malaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

A role for B cells in the development of T cell helper function in a malaria infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The spleen, IgG antibody subsets and immunity to Plasmodium berghei in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Association of malaria with inactivation of alpha1,3-galactosyl transferase in catarrhines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies and Plasmodium falciparum merozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antigenic variation in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Rapid switching to multiple antigenic and adhesive phenotypes in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Dendritic cells can initiate protective immune responses against malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

T cell-mediated immunity in murine malaria. II. Induction of protective immunity to P. chabaudi by antigen fed macrophages and antigen educated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Infective dose modulates the balance between Th1- and Th2-regulated immune responses during blood-stage malaria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Cellular responses to Plasmodium falciparum major surface antigens and their relationship to human activities associated with malaria transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

alpha beta and gamma delta T cells in the immune response to the erythrocytic stages of malaria in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Malaria-induced increase of splenic gamma delta T cells in humans, monkeys, and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Molecular and cellular basis of interleukin 12 activity in prophylaxis and therapy against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Interleukin-12-dependent mechanisms in the clearance of blood-stage murine malaria parasite Plasmodium berghei XAT, an attenuated variant of P. berghei NK65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Low interleukin-12 activity in severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Protective immunity to erythrocytic Plasmodium chabaudi AS infection involves IFNgamma-mediated responses and a cellular infiltrate to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The inhibition of Plasmodium falciparum growth in vitro by sera from mice infected with malaria or treated with TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Tumor necrosis factor and disease severity in children with falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Cytokine expression in the brain in human cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Nitric oxide and human infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The role of TH1 and TH2 cells in a rodent malaria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Immune effector mechanisms in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Immunization against blood-stage rodent malaria using purified parasite antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Specificity of the protective antibody response to apical membrane antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Humoral and cellular immune responses to synthetic peptides from the Plasmodium falciparum blood-stage antigen, Pf155/RESA, in Cameroonian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Inhibition of in vitro growth of plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Malaria multigene families: the price of chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

The malaria vaccine: anti-parasite or anti-disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

Adjuvants--a classification and review of their modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2002.01107.X

10.1046/J.1440-1711.2002.01107.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12225376